
    
      This study was aimed to investigate the effect of metformin on the gut microbiota and
      glycemic control in newly diagnosed type 2 diabetes patients. All the recurited patients were
      treated with metformin 1500-2000mg daily for 3 months. Stool specimens and blood samples were
      collected at the beginning and 3 months later.
    
  